By Mary Chapman Lupus News Today Copyright © 2013-2018 All rights reserved. Completion of a second round of funding could help bring closer to market Progentec Diagnostics‘ new tool for predicting lupus flares and a biomarker-based index that monitors underlying disease activity. Funding for Progentec’s biomarker-based diagnostic testing was led by venture capital outfits i2ERead more
News
By Journal Record Staff Courtesy of the Journal Record OKLAHOMA CITY – Progentec Diagnostics Inc. has completion a second round of funding led by i2E, along with Chicago-based OCA Ventures and NMC Lifesciences, a health care provider. The funding will help bring Oklahoma City-based Progentec’s tool for identifying lupus flare-ups and a biomarker-based disease-activityRead more
– New funding brings lupus-detection tools closer to commercialization – Acquisition of LupusCorner marks a step forward in developing a first-in-class lupus-management platform OKLAHOMA CITY, Nov. 1, 2018 /PRNewswire/ — Progentec Diagnostics, Inc. (“Progentec”), a leader in the development of technological innovations in the field of diagnostics, today announced the completion of a second roundRead more
By CAROLINA HENRIQUES Lupas News Today Progentec Diagnostics is closer to marketing a new set of tools for predicting lupus flares after obtaining $1.25 million in financing. The Oklahoma Medical Research Foundation created the technology the company is using. Progentec is collaborating with Dr. Judith James, a lupus researcher who developed the technology, to refineRead more
By Scott Meacham Copyright © The Oklahoma Publishing Co. Every year around the middle of October, I start writing in my head at least one holiday-focused column before the end of the year. I try to jot down a few ideas, feeling good that I have started well in advance, and then the whirlwind ofRead more
By Paula Burkes Copyright © 2017, The Oklahoma Publishing Co. Scientists don’t yet know why some 1.5 million Americans have lupus, an autoimmune disease in which the body attacks its own healthy tissues. Symptoms surface mostly in women ages 16 to 34 and vary from rashes and joint pain to deadly organ failure. Physician-scientist JudithRead more
By Scott Meacham Copyright © 2017, The Oklahoma Publishing Co. Over the last year, Progentec Diagnostics, a startup that is focused on developing breakthrough diagnostics, has made significant progress on a diagnostic test to identify patients at increased risk for flare in lupus. Lupus is a viciously painful disease that generally surfaces in women inRead more
I get really excited when I see an Oklahoma startup improving the lives of people who have incurable debilitating disease. That’s the story of Progentec Diagnostics, a startup that is focused on developing breakthrough diagnostics. The firm’s initial focus is on developing a diagnostic test to identify patients at increased risk for flare in lupus, an incurable autoimmune disease that afflicts 1.5 million patients in the U.S.
